EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro

Mümtaz Güran iD, Kadir Çakıral iD, Kerem Teralı iD, Tülay Kandemir iD, Gizem Şanlıtürk iD, Melda Meral Öcal iD, Toğrul Nagiyev iD, Fatih Köksal iD

Pathogens and Disease · 2023

DOI: 10.1093/femspd/ftad007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens and Disease, 2023. Verfasst von Mümtaz Güran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Faculty of Medicine, Eastern Mediterranean University, 99628 Famagusta, N. Cyprus via Mersin 10, Turkey. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Acinetobacter Infections, Anti-Infective Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several studies have demonstrated that the effectiveness of carbapenems against drug-resistant Acinetobacter baumannii infections has been decreasing. Combination therapy with two or more drugs is currently under investigation to overcome the emerging resistance against carbapenems. In this study, we tested the possible synergistic interactions of a potent antibacterial flavonoid, baicalein, with meropenem to illustrate this duo’s antibacterial and antibiofilm effects on 15 extensively drug resistant or pan-drug-resistant (XDR/PDR) A. baumannii clinical isolates in vitro. Isolates included in the study were identified with MALDI-TOF MS, and antibiotic resistance patterns were studied according to EUCAST protocols. Carbapenem resistance was confirmed with the modified Hodge test, and resistance genes were also analyzed with genotypical methods. Then, checkerboard and time-kill assays were performed to analyze antibacterial synergism. Additionally, a biofilm inhibition assay was performed for screening the antibiofilm activity. To provide structural and mechanistic insights into baicalein action, protein–ligand docking, and interaction profiling calculations were conducted. Our study shed light on the remarkable potential of the baicalein–meropenem combination, since either synergistic or additive antibacterial activity was observed against every XDR/PDR A. baumannii strain in question. Furthermore, the baicalein–meropenem combination displayed significantly better antibiofilm activity in contrast to standalone use. In silico studies predicted that these positive effects arose from inhibition by baicalein of A. baumannii beta-lactamases and/or penicillin-binding proteins. Overall, our findings highlight the prospective potential benefits of baicalein in combination with meropenem for the treatment of carbapenem-resistant A. baumannii infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAcinetobacter InfectionsAnti-Infective AgentsHumansMeropenemDrug SynergismAnti-Bacterial AgentsCarbapenemsMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialFlavanones

Stichwörter der Autor:innen

Acinetobacter baumanniibaicaleincarbapenemsynergy

Substanzen

MeropenemAnti-Bacterial AgentsCarbapenemsAnti-Infective AgentsbaicaleinFlavanones

Autor:innen und Institutionen

  • Department of Medical Microbiology, Faculty of Medicine, Eastern Mediterranean University, 99628 Famagusta, N. Cyprus via Mersin 10, Turkey.
  • Department of Chemistry, Faculty of Arts and Sciences, Eastern Mediterranean University, 99628 Famagusta, N. Cyprus via Mersin 10, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Cyprus International University, 99258 N. Cyprus via Mersin 10, Turkey.
  • Department of Medical Microbiology, Faculty of Medicine, Çukurova University, 1380 Adana, Turkey.
  • Department of Biotechnology, Faculty of Science, The Campus of Çiftlikköy, Mersin University, 33343 Yenişehir, Mersin, Turkey.

ORCID-Profile: Mümtaz Güran, Kadir Çakıral, Kerem Teralı, Tülay Kandemir, Gizem Şanlıtürk, Melda Meral Öcal, Toğrul Nagiyev, Fatih Köksal

Zitieren

APA

Güran, M., Çakıral, K., Teralı, K., Kandemir, T., Şanlıtürk, G., Öcal, M. M., Nagiyev, T., & Köksal, F. (2023). Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Pathogens and Disease. https://doi.org/10.1093/femspd/ftad007

Vancouver

Güran M, Çakıral K, Teralı K, Kandemir T, Şanlıtürk G, Öcal MM, et al. Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro. Pathogens and Disease. 2023. doi:10.1093/femspd/ftad007

BibTeX
@article{Gran2023,
  author = {Güran, Mümtaz and Çakıral, Kadir and Teralı, Kerem and Kandemir, Tülay and Şanlıtürk, Gizem and Öcal, Melda Meral and Nagiyev, Toğrul and Köksal, Fatih},
  title = {Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro},
  journal = {Pathogens and Disease},
  year = {2023},
  doi = {10.1093/femspd/ftad007}
}
Kostenlos starten →